Prostaglandins in the pathogenesis of kidney diseases

39Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

Abstract

Prostaglandins (PGs) are important lipid mediators produced from arachidonic acid via the sequential catalyzation of cyclooxygenases (COXs) and specific prostaglandin synthases. There are five subtypes of PGs, namely PGE2, PGI2, PGD2, PGF2a, and thromboxane A2 (TXA2). PGs exert distinct roles by combining to a diverse family of membrane-spanning G protein-coupled prostanoid receptors. The distribution of these PGs, their specific synthases and receptors vary a lot in the kidney. This review summarized the recent findings of PGs together with the COXs and their specific synthases and receptors in regulating renal function and highlighted the insights into their roles in the pathogenesis of various kidney diseases.

Cite

CITATION STYLE

APA

Li, Y., Xia, W., Zhao, F., Wen, Z., Zhang, A., Huang, S., … Zhang, Y. (2018, May 29). Prostaglandins in the pathogenesis of kidney diseases. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.25005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free